ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,503Medicare Part D Prescriptions Filled, Including Refills

Rank: 57 out of 5176

$2.46M Total Retail Price of All Prescriptions

Rank: 28 out of 5176

497 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 497 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 21,774 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

58% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$105 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

47 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
EVISTA 1,257 1,154 10 1 65
ALENDRONATE SODIUM 1,058 1,028 2 18
NEXIUM 909 813 3 16
LIDODERM 788 764 4 59
AMLODIPINE BESYLATE 769 727 5 2
CRESTOR 707 662 6 15
METOPROLOL SUCCINATE 641 626 7 11
LOVAZA 536 477 8 43
TAMSULOSIN HCL 499 483 9 20
DIOVAN HCT 490 456 10 39
PLAVIX 444 424 11 29
SIMVASTATIN 442 404 12 1
ALLOPURINOL 430 404 13 41
DIOVAN 430 421 13 19
AZITHROMYCIN 408 366 15 42
CELEBREX 405 373 16 80
CLOPIDOGREL 372 352 17 26
AMMONIUM LACTATE 340 323 18 91
ATORVASTATIN CALCIUM 286 264 19 9
CREON 285 276 20 111
AVODART 285 283 20 107
ATENOLOL 281 257 22 12
PATADAY 280 244 23 220
GABAPENTIN 257 228 24 21
TRIAMCINOLONE ACETONIDE 252 228 25 125
METFORMIN HCL 244 227 26 7
SINGULAIR 230 223 27 62
MECLIZINE HCL 219 204 28 81
CHLORHEXIDINE GLUCONATE 216 191 29 202
GLIMEPIRIDE 215 186 30 37
FLUTICASONE PROPIONATE 206 164 31 38
VOLTAREN 202 176 32 97
ISOSORBIDE MONONITRATE ER 181 181 33 44
DONEPEZIL HCL 180 172 34 28
FLECTOR 177 173 35 282
OMEPRAZOLE 176 164 36 3
CLOBETASOL EMOLLIENT 167 153 10 37 541
TRILIPIX 163 163 38 187
LOSARTAN POTASSIUM 162 150 39 14
ACTONEL 158 130 40 134
ZOLPIDEM TARTRATE 153 146 41 17
CIPROFLOXACIN HCL 152 140 42 84
SYMBICORT 151 131 43 120
AMLODIPINE BESYLATE-BENAZEPRIL 145 114 44 55
CLOBETASOL PROPIONATE 140 136 45 130
JANUVIA 138 132 46 25
SYNTHROID 135 112 47 33
VIREAD 133 121 48 250
MONTELUKAST SODIUM 126 111 49 123
GLYBURIDE-METFORMIN HCL 122 122 R 50 76
ACTOS 121 106 51 85
LIPITOR 117 114 52 51
THEO-24 115 115 53 594
LOSARTAN-HYDROCHLOROTHIAZIDE 112 112 54 35
CARBIDOPA-LEVODOPA 103 103 55 98
NASONEX 103 96 55 178
PATANOL 101 94 57 158
FLUOCINONIDE 100 96 58 165
SINGLE USE SWAB 98 76 59 108
DOXAZOSIN MESYLATE 97 97 60 103
TRIAMTERENE-HCTZ 96 95 61 86
FINASTERIDE 95 92 62 69
CYMBALTA 93 93 63 90
PROCTOZONE-HC 91 84 64 171
EXFORGE 85 85 65 126
COMBIVENT 84 84 66 156
BYSTOLIC 83 82 67 96
AMITRIPTYLINE HCL 81 80 R 68 177
LEVOTHYROXINE SODIUM 78 64 69 4
ALFUZOSIN HCL 77 71 70 462
NAMENDA 77 77 70 47
GLIPIZIDE XL 77 67 70 83
CARVEDILOL 77 53 70 24
VALSARTAN-HYDROCHLOROTHIAZIDE 69 61 74 292
RANITIDINE HCL 68 66 75 36
JANUMET 66 55 76 77
CLOTRIMAZOLE-BETAMETHASONE 66 52 76 94
HYDROXYZINE HCL 65 54 R 78 213
PROAIR HFA 64 57 79 60
ULORIC 64 51 79 280
ACTOPLUS MET 63 50 81 268
MELOXICAM 61 55 82 53
LIDOCAINE 61 55 82 179
VYTORIN 61 47 82 152
TRICOR 60 55 85 148
FUROSEMIDE 56 56 86 8
PRAMIPEXOLE DIHYDROCHLORIDE 55 55 87 339
LACLOTION 53 53 88 299
URSODIOL 52 52 89 405
MUPIROCIN 52 47 89 182
POLYETHYLENE GLYCOL 3350 51 45 91 74
PROPYLTHIOURACIL 51 51 91 607
METOPROLOL TARTRATE 50 43 93 6
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 18, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.